Do you want to read an article? Please log in or register.
Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2
Macular Diseases
Related content
Macular Diseases
MESOPIC AND DARK-ADAPTED TWO-COLOR FUNDUS-CONTROLLED PERIMETRY IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Retina.
Pfau M, Müller PL, von der Emde L, Lindner M, Möller PT, Fleckenstein M, Holz FG, Schmitz-Valckenberg S
doi: 10.1097/IAE.
COMMENTED
Retinal Diseases
RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2
Retina.
Spaide RF, Yannuzzi LA, Maloca PM
doi: 10.1097/IAE.
Macular Diseases
Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration
Ophthalmology.
Laíns I, Miller JB, Park DH, Tsikata E, Davoudi S, Rahmani S, Pierce J, Silva R, Chen TC, Kim IK, Vavvas D, Miller JW, Husain D
doi: 10.1016/j.ophtha.2017.03.061.
Peripheral Changes Associated with Delayed Dark Adaptation in Age-related Macular Degeneration
Am J Ophthalmol.
Laíns I, Park DH, Mukai R, Silverman R, Oellers P, Mach S, Kim IK, Vavvas DG, Miller JW, Miller JB, Husain D
doi: 10.1016/j.ajo.2018.03.035.
Macular Diseases
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
BMC Ophthalmol
Ahmed D, Stattin M, Haas AM, Graf A, Krepler K, Ansari-Shahrezaei S
doi: 10.1186/s12886-020-01651-2
COMMENTED
Blindness and Vision Impairment
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
BMJ
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM
doi: 10.1136/bmj.m4573
Macular DiseasesRetinal Diseases
Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group
Ophthalmology.
Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2), Domalpally A, Clemons TE, Danis RP, Sadda SR, Cukras CA, Toth CA, Friberg TR, Chew EY
doi: 10.1016/j.ophtha.2016.12.004.
Macular Diseases
The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration
Ophthalmology.
Mullins RF, McGwin G Jr, Searcey K, Clark ME, Kennedy EL, Curcio CA, Stone EM, Owsley C
doi: 10.1016/j.ophtha.2018.10.037.
Macular Diseases
Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks
JAMA Ophthalmol.
Burlina PM, Joshi N, Pekala M, Pacheco KD, Freund DE, Bressler NM
doi: 10.1001/